Solventum said sales for Q3 2025 ended September 30 increased 0.7% to $2,096 million, with organic sales up 2.7%, GAAP diluted earnings per share of $7.22 and adjusted diluted earnings per share of $1.50.

1. 01

   Solventum said sales for Q3 2025 ended September 30 increased 0.7% to $2,096 million, with organic sales up 2.7%, GAAP diluted earnings per share of $7.22 and adjusted diluted earnings per share of $1.50.

2. 02

   The company completed the sale of its Purification and Filtration business on September 1, 2025, with operating income for Q3 of $1,690 million including a gain on sale of business of $1,518 million.

3. 03

   Solventum said operating cash flow for Q3 2025 was $75 million, purchases of property, plant and equipment were $97 million, and free cash flow was ($22) million.

4. 04

   The company said once fully implemented, its 4-year 'Transform for the Future' initiative is expected to generate approximately $500 million in annual cost savings, with cumulative pretax costs of approximately $500 million, and it increased its full-year adjusted EPS outlook to $5.98 to $6.08 from the prior range of $5.88 to $6.03.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.